NASDAQ:ALXO

Alx Oncology Holdings Stock Predictions

etoro logo Buy ALXO
*Your capital is at risk
$1.67
-0.110 (-6.18%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

ALXO Prediction Chart

ALXO Predictions History

Latest community submissions for ALXO.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 4, 2026 $1.80 -3.53% $2.01 X 89.75% 0
Feb 4, 2026 $1.83 -2.21% $2.01 X 90.98% 0
Feb 4, 2026 $1.83 -2.14% $2.01 X 91.04% 0
Dec 4, 2025 $1.49 +12.88% $1.37 V 91.24% 1
Dec 1, 2025 $1.43 +4.56% $1.32 X 91.48% 0
Dec 1, 2025 $1.41 +2.85% $1.32 X 93.26% 0
Dec 1, 2025 Bullish $1.32 X 0
Jan 31, 2025 $1.38 +5.11% $1.46 V 94.31% 1
Jan 31, 2025 $1.35 +3.05% $1.46 V 92.46% 1
Jan 31, 2025 Bearish $1.46 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALXO with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ALX ONCOLOGY HOLDINGS INC.
ALX Oncology Holdings
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin's lymphoma, as well as a range of solid tumor indications, including head and neck squamous cell c...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE